AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 43 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,961,000 | +61.7% | 580,000 | +132.0% | 1.85% | +114.2% |
| Q3 2021 | $2,450,000 | -35.1% | 250,000 | -55.4% | 0.86% | -42.7% |
| Q2 2021 | $3,776,000 | -61.9% | 561,011 | -48.8% | 1.51% | -57.7% |
| Q1 2021 | $9,899,000 | +110.1% | 1,095,000 | +55.3% | 3.57% | +178.4% |
| Q4 2020 | $4,711,000 | +32.6% | 705,218 | 0.0% | 1.28% | +32.8% |
| Q3 2020 | $3,554,000 | -74.9% | 705,218 | -59.8% | 0.96% | -76.4% |
| Q2 2020 | $14,158,000 | -32.4% | 1,752,218 | -34.5% | 4.09% | -59.7% |
| Q1 2020 | $20,949,000 | +70.7% | 2,673,718 | +64.5% | 10.15% | +234.2% |
| Q4 2019 | $12,269,000 | – | 1,625,000 | – | 3.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 520,830 | $2,625,000 | 1.69% |
| COWEN AND COMPANY, LLC | 1,905,990 | $9,606,000 | 1.57% |
| Ghost Tree Capital, LLC | 825,000 | $4,158,000 | 1.20% |
| GENDELL JEFFREY L | 1,115,211 | $5,621,000 | 1.18% |
| Vivo Capital, LLC | 3,526,093 | $17,772,000 | 1.03% |
| ACUTA CAPITAL PARTNERS, LLC | 705,218 | $3,554,000 | 0.96% |
| RTW INVESTMENTS, LP | 5,366,705 | $27,048,000 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 2,840,669 | $14,317,000 | 0.50% |
| Avoro Capital Advisors LLC | 4,200,000 | $21,168,000 | 0.30% |
| HighVista Strategies LLC | 57,495 | $290,000 | 0.21% |